Event Date/Time: Apr 28, 2010
End Date/Time: Apr 30, 2010
Following the much anticipated release of FDAâ€™s Draft Guidance, this event is timely planned to provide the adaptive community an opportunity to interact with the FDA and other industry experts to determine the impact of the new Guidance. Program sessions will provide regulatory guidance as well as advise the adaptive community on how to overcome the design and implementation obstacles to adaptive development. Focused solely on adaptive clinical drug development, this event will cover regulatory updates and issues, the latest adaptive innovations and methodologies, case studies, drug supply and management, and lessons learned from real life adaptive implementation.